Last Updated: November 10, 2026

Mylan Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN LABS LTD

MYLAN LABS LTD has sixty-six approved drugs.

There are seven tentative approvals on MYLAN LABS LTD drugs.

Summary for Mylan Labs Ltd

US Patents:	0
Tradenames:	53
Ingredients:	51
NDAs:	66

Drugs and US Patents for Mylan Labs Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Labs Ltd	NOREPINEPHRINE BITARTRATE	norepinephrine bitartrate	INJECTABLE;INJECTION	211242-001	Oct 4, 2018	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Labs Ltd	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	090243-001	May 11, 2010	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Labs Ltd	RIFAMPIN	rifampin	INJECTABLE;INJECTION	065421-001	May 22, 2008	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Labs Ltd	LEUCOVORIN CALCIUM PRESERVATIVE FREE	leucovorin calcium	INJECTABLE;INJECTION	203800-003	May 19, 2017	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Labs Ltd	NORETHINDRONE AND ETHINYL ESTRADIOL	ethinyl estradiol; norethindrone	TABLET;ORAL-28	200488-001	Oct 21, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Labs Ltd	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	076889-001	Mar 25, 2005		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Labs Ltd	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	091554-001	Sep 19, 2011	AP	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.